Exscientia plc (NASDAQ:EXAI) Sees Large Decrease in Short Interest

Exscientia plc (NASDAQ:EXAI - Get Free Report) saw a significant drop in short interest during the month of September. As of September 30th, there was short interest totalling 2,890,000 shares, a drop of 9.7% from the September 15th total of 3,200,000 shares. Based on an average daily trading volume, of 676,600 shares, the days-to-cover ratio is currently 4.3 days. Approximately 2.7% of the company's shares are sold short.

Exscientia Trading Down 4.3 %

Shares of NASDAQ:EXAI traded down $0.23 on Thursday, hitting $5.06. 577,434 shares of the company's stock were exchanged, compared to its average volume of 644,563. The stock has a market capitalization of $611.69 million, a price-to-earnings ratio of -3.86 and a beta of 0.84. Exscientia has a 12 month low of $3.80 and a 12 month high of $7.91. The company has a debt-to-equity ratio of 0.06, a current ratio of 5.93 and a quick ratio of 5.93. The business's 50 day simple moving average is $5.14 and its two-hundred day simple moving average is $5.06.

Exscientia (NASDAQ:EXAI - Get Free Report) last released its quarterly earnings data on Thursday, August 15th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.31) by ($0.05). The company had revenue of $5.60 million during the quarter. Exscientia had a negative net margin of 620.99% and a negative return on equity of 37.56%. Analysts anticipate that Exscientia will post -1.25 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the company. GAMMA Investing LLC grew its holdings in Exscientia by 112.1% during the 1st quarter. GAMMA Investing LLC now owns 4,356 shares of the company's stock worth $25,000 after acquiring an additional 2,302 shares in the last quarter. China Universal Asset Management Co. Ltd. increased its holdings in Exscientia by 76.8% during the first quarter. China Universal Asset Management Co. Ltd. now owns 9,274 shares of the company's stock valued at $53,000 after buying an additional 4,029 shares during the period. EntryPoint Capital LLC raised its stake in Exscientia by 22.8% in the first quarter. EntryPoint Capital LLC now owns 31,171 shares of the company's stock worth $178,000 after buying an additional 5,784 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in Exscientia by 108.8% during the second quarter. Bank of New York Mellon Corp now owns 388,459 shares of the company's stock worth $1,981,000 after buying an additional 202,377 shares during the period. Finally, Federated Hermes Inc. purchased a new position in shares of Exscientia in the 2nd quarter valued at $115,000. 41.58% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

EXAI has been the topic of several recent analyst reports. TD Cowen reissued a "hold" rating on shares of Exscientia in a research note on Friday, August 9th. Barclays reissued an "equal weight" rating and issued a $5.00 price objective on shares of Exscientia in a research report on Tuesday, August 13th.

About Exscientia

Exscientia plc, an artificial intelligence (AI) driven Pharma-tech company, engages in design and develop differentiated medicines for diseases with high unmet patient needs. The company's lead product candidate GTAEXS617, a CDK7 inhibitor, which is currently in a Phase 1/2 trial to manage the potential toxicities associated with CDK7 as well as optimizing pharmacokinetics for maximizing on-target efficacy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.